Department of Pharmacy, Division of Toxicology, Sungkyunkwan University, 2066 Sebu-ro, Suwon, Gyeonggi, 16419, Republic of Korea.
Toxicology, College of Pharmacy, Dankook University, 119 Dandae-ro, Cheonan, Chungnam, 31116, Republic of Korea.
Arch Toxicol. 2020 Mar;94(3):887-909. doi: 10.1007/s00204-020-02657-x. Epub 2020 Feb 20.
Polyhexamethylene guanidine phosphate (PHMG-p) was used as a humidifier disinfectant in Korea. PHMG induced severe pulmonary fibrosis in Koreans. The objective of this study was to elucidate mechanism of pulmonary toxicity caused by PHMG-p in rats using multi-omics analysis. Wistar rats were intratracheally instilled with PHMG-p by single (1.5 mg/kg) administration or 4-week (0.1 mg/kg, 2 times/week) repeated administration. Histopathologic examination was performed with hematoxylin and eosin staining. Alveolar macrophage aggregation and granulomatous inflammation were observed in rats treated with single dose of PHMG-p. Pulmonary fibrosis, chronic inflammation, bronchiol-alveolar fibrosis, and metaplasia of squamous cell were observed in repeated dose group. Next generation sequencing (NGS) was performed for transcriptome profiling after mRNA isolation from bronchiol-alveoli. Bronchiol-alveoli proteomic profiling was performed using an Orbitrap Q-exactive mass spectrometer. Serum and urinary metabolites were determined using H-NMR. Among 418 differentially expressed genes (DEGs) and 67 differentially expressed proteins (DEPs), changes of 16 mRNA levels were significantly correlated with changes of their protein levels in both single and repeated dose groups. Remarkable biological processes represented by both DEGs and DEPs were defense response, inflammatory response, response to stress, and immune response. Arginase 1 (Arg1) and lipocalin 2 (Lcn2) were identified to be major regulators for PHMG-p-induced pulmonary toxicity based on merged analysis using DEGs and DEPs. In metabolomics study, 52 metabolites (VIP > 0.5) were determined in serum and urine of single and repeated-dose groups. Glutamate and choline were selected as major metabolites. They were found to be major factors affecting inflammatory response in association with DEGs and DEPs. Arg1 and Lcn2 were suggested to be major gene and protein related to pulmonary damage by PHMG-p while serum or urinary glutamate and choline were endogenous metabolites related to pulmonary damage by PHMG-p.
聚六亚甲基胍磷酸盐(PHMG-p)曾在韩国被用作加湿器消毒剂。PHMG-p 可导致韩国人群发生严重的肺纤维化。本研究旨在通过多组学分析阐明 PHMG-p 诱导大鼠肺毒性的作用机制。Wistar 大鼠经气管内单次(1.5mg/kg)或重复(0.1mg/kg,每周 2 次)4 周给药 PHMG-p。采用苏木精-伊红染色进行组织病理学检查。单次给药 PHMG-p 可导致肺泡巨噬细胞聚集和肉芽肿性炎症。重复给药组可观察到肺纤维化、慢性炎症、细支气管-肺泡纤维化和鳞状细胞化生。从细支气管-肺泡中提取 mRNA 后进行下一代测序(NGS)进行转录组谱分析。使用 Orbitrap Q-exactive 质谱仪进行细支气管-肺泡蛋白质组学分析。采用 H-NMR 测定血清和尿液代谢物。在 418 个差异表达基因(DEGs)和 67 个差异表达蛋白(DEPs)中,单次和重复剂量组中 16 个 mRNA 水平的变化与它们的蛋白水平变化显著相关。以 DEGs 和 DEPs 为代表的显著生物学过程为防御反应、炎症反应、应激反应和免疫反应。精氨酸酶 1(Arg1)和脂联素 2(Lcn2)被鉴定为基于 DEGs 和 DEPs 合并分析的 PHMG-p 诱导肺毒性的主要调节因子。在代谢组学研究中,在单次和重复剂量组的血清和尿液中确定了 52 种(VIP>0.5)代谢物。谷氨酸和胆碱被选为主要代谢物。它们被发现是与 DEGs 和 DEPs 相关的影响炎症反应的主要因素。Arg1 和 Lcn2 被认为是 PHMG-p 导致肺损伤的主要基因和蛋白,而血清或尿液中的谷氨酸和胆碱是与 PHMG-p 导致肺损伤相关的内源性代谢物。